Avantor (AVTR) Asset Writedowns and Impairment (2023 - 2024)

Avantor's (AVTR) quarterly Asset Writedowns and Impairment came in at $54.4 million in Q2 2024, down 48.87% year-on-year from $106.4 million in Q3 2023, and down 48.87% quarter-over-quarter from $106.4 million in Q2 2023.

Avantor (AVTR) Asset Writedowns and Impairment (2023 - 2024) Analysis & Trends

Avantor's Asset Writedowns and Impairment history runs 2 years deep, the most recent figure standing at $54.4 million for Q2 2024.

  • On a quarterly basis, Asset Writedowns and Impairment fell 48.87% year-over-year to $54.4 million in Q2 2024; TTM through Jun 2024 was $160.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $785.0 million, changed N/A from the prior year.
  • Asset Writedowns and Impairment retreated to $54.4 million in Q2 2024 per AVTR's latest filing, from $106.4 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $106.4 million in Q2 2023 and bottomed at $54.4 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn
10 Avantor 7.67 Bn 7.39 Bn 500.70 Mn

Historic Data

Download Data
DateValue
Jun 30, 2024 54.40 Mn
Jun 30, 2024 54.40 Mn
Jun 30, 2023 106.40 Mn
Jun 30, 2023 106.40 Mn